Aug 3 (Reuters) – Supernus Pharmaceuticals and Indivior Pharmaceuticals said on Monday they had agreed to an all-stock merger that would create a company with about $2.2 billion in annual revenue and a portfolio of medicines for neurological, psychiatric and addiction-related conditions. Shares of S
Aug 3 (Reuters) – Vaccine maker GlaxoSmithKline Pharmaceuticals reported a 15.7% rise in first-quarter profit on Monday, aided by stable demand across its vaccine and drug portfolio, including respiratory and specialty medicines. Here are some more details: • Profit for the first quarter ended June
By Maggie Fick LONDON, Aug 3 (Reuters) – AstraZeneca investors punished the pharmaceutical firm on Monday over reports of merger talks with U.S. rival Bristol Myers Squibb that could make one of the world’s biggest drugmakers with a combined value of nearly $400 billion. Shares in AstraZeneca closed
BUNIA, Congo (AP) — Esther Lutula stopped going for prenatal checkups shortly after the current Ebola outbreak was declared in eastern Congo. Midway into her pregnancy, the 26-year-old feared being put into isolation simply for having a fever, a common misconception. “That’s why I’m waiting until th
Aug 3 (Reuters) – Swiss generic drugmaker Sandoz said on Monday that it has entered into a $450 million settlement agreement with 43 U.S. states and territories to resolve litigations concerning alleged anti-competitive conduct in the U.S. market for generic medicines. Under the agreement, the firm’
PLYMOUTH, Mass. (AP) — After an opening week of wrenching testimony and a jury trip to the home where Lindsay Clancy strangled her three children, her murder trial resumes Monday with more testimony about the killings in a coastal Massachusetts town in 2023. Monday’s witnesses are expected to includ
By Sabrina Valle and Michael Erman Aug 2 (Reuters) – AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world’s biggest pharmaceutical companies with a combined value of nearly $400 billion, according to a person familiar w
By Danielle Kaye NEW YORK, Aug 2 (Reuters) – Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time in over three decades after losing 80 pounds on weight-loss drug Mounjaro. Earlier this year, the Denver bankruptcy lawyer walked into a Macy’s and found herself overwhelmed. “R
Massachusetts is on the way to giving doctors the final say on whether an abortion should be allowed late in pregnancy, a move expected to affect few cases but that supporters say is needed because hospitals are now turning away women they should be serving. The state Senate adopted the measure Frid
July 31 (Reuters) – Becton Dickinson said on Friday it is issuing a recall on certain lots of medical needle sets in the U.S. after users reported difficulty in removing a part of the device after using it on patients. Here are some details: • The product, called an intraosseous needle set, is used
July 31 (Reuters) – Democratic Republic of Congo’s fast-spreading Ebola outbreak started in January, or even earlier, in the eastern Ituri province, a report published in the journal Science showed. • The report, based on interviews with 97 people, concluded that the outbreak had begun at least in J
July 31 (Reuters) – India’s Glenmark Pharmaceuticals posted a 53.6% jump in adjusted first-quarter profit on Friday, led by strong demand for its drugs that treat long-term illnesses. The company’s consolidated profit before exceptional items and taxes rose to 6.43 billion rupees ($67.41 million) fo
By Oscar Martinez and Stefanie Eschenbacher LAS CHOAPAS, Mexico, July 31 (Reuters) – Nearly five months after an accident ignited a fire at a natural gas well in rural Veracruz, Mexico, residents are growing increasingly concerned about potential health and environmental impacts as large volumes of
By Siddhi Mahatole and Puyaan Singh July 31 (Reuters) – AbbVie slightly trimmed its 2026 profit forecast on Friday to account for its planned Apogee Therapeutics acquisition, while topping second-quarter estimates on strong immunology drug sales. The company agreed in June to buy Apogee for $10.9 bi
BUCHAREST, July 31 (Reuters) – Romanian healthcare workers ended a nationwide strike on Friday as the country’s caretaker government approved new hires in short-staffed state hospitals. About two-third of doctors, nurses and other health workers at 400 hospitals across the country went on strike for
By Sneha S K and Bhanvi Satija July 31 (Reuters) – Novo Nordisk said on Friday its experimental cardiovascular drug failed to show benefit in a late-stage study, dealing a blow to the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes drugs. The company shares fell 7
By Mariam Sunny and Christy Santhosh July 31 (Reuters) – Moderna beat Wall Street estimates for second-quarter revenue on Friday, helped by vaccine partnership payments and international sales of its COVID-19 shot, as investors await a key U.S. decision on its flu vaccine. The biotech is betting on
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid July 31 (Reuters) – We also report a new and improved way of monitoring Parkinson’s disease medication levels. IMMUNOTHERAPY CAN PREVENT BLADDER REMOVAL FOR CANCER
By Christy Santhosh July 31 (Reuters) – Shares of Replimune more than doubled premarket on Friday after the U.S. Food and Drug Administration’s panel of outside advisers voted to back trial results for its drug for a type of skin cancer. Late on Thursday, the panel voted 10 to 3 in favor of the drug
By Kashish Tandon July 31 (Reuters) – India’s Sun Pharmaceutical Industries reported a 27% rise in first-quarter profit on Friday, driven by robust growth in its high-margin specialty medicines business as the country’s largest drugmaker continues to pivot beyond traditional generic drugs. The resul
By Vivek Kumar M July 31 (Reuters) – Manipal Health Enterprises’ $960.4 million initial public offering was fully subscribed on the final day of bidding on Friday, led by institutional investors, while valuation worries kept retail investors on the sidelines. The IPO, India’s second biggest this yea
By Clement Bonnerot and AyenDeng Bior July 31 (Reuters) – The Ebola outbreak is the second largest on record globally, government data showed on Friday, as transmission continues to outpace efforts to contain the disease. Congo reported 3,532 cases on Friday, surpassing the total 3,481 cases recorde
July 31 (Reuters) – Finland has detected African swine fever for the first time after laboratory tests confirmed the virus in a wild boar in eastern Finland, the Finnish Food Authority said in a statement issued on Thursday. • The virus, which is harmless to humans but highly contagious and deadly i
By Simon Ferdinand Eibach and Kira Britten July 31 (Reuters) – Medical technology firm Siemens Healthineers on Friday cut its 2026 revenue growth forecast to a range of 3.5% to 4% due to weakness in its diagnostic business, weighed down by China’s procurement policy and a migration to a new laborato
July 30 (Reuters) – U.S. medical device maker Stryker on Thursday beat Wall Street estimates for second-quarter results, aided by strong demand for its implants and devices used in complex procedures ranging from spinal to orthopedic surgeries. However, the company’s shares fell 9% in extended tradi
By Puyaan Singh July 30 (Reuters) – The U.S. Food and Drug Administration’s panel of outside advisers on Thursday voted to back results from a trial studying Replimune’s drug for a type of skin cancer. The FDA had declined to approve the drug, RP1, for a second time in April, citing reliance on a st
July 30 (Reuters) – Medical device maker Dexcom raised its full-year revenue forecast and beat quarterly estimates on Thursday, banking on sustained demand for its continuous glucose monitors that track blood sugar levels, sending shares of the company up over 4% in extended trading. Here are the de
By Jonathan Stempel NEW YORK, July 30 (Reuters) – A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars of over-the-counter decongestants that didn’t work.
Nichole Sims started using a tanning bed at 15 because she said everyone around her was doing it, especially before events like homecoming dances and prom. Eight years later, she was diagnosed with melanoma — a potentially life-threatening skin cancer. During that time, Sims has seen tanning become
NEW YORK (AP) — Millions of older adults on Medicare prescription drug coverage could face steeper monthly costs in 2027, after the Trump administration concludes a temporary subsidy program that has helped offset premiums for the past two years. The Centers for Medicare & Medicaid Services this wee
